NCT05418543 is a NA clinical trial of Endoscopic ultrasound with fine needle biopsy in Inoperable Disease, sponsored by Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor.

What drugs are being tested in NCT05418543?

Interventions in NCT05418543: Endoscopic ultrasound with fine needle biopsy.

What condition does NCT05418543 study?

NCT05418543 studies Inoperable Disease, Bile Duct Cancer.

Is NCT05418543 still recruiting?

NCT05418543 is currently status unknown. Last updated 15 June 2022.

Last reviewed 2022-06-15 · How we verify

NCT05418543

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CH-EUS in Diagnosis of Inoperable Bile Duct Tumors

Status unknown NA Last updated 15 June 2022

What this trial tests

NA trial testing Endoscopic ultrasound with fine needle biopsy in Inoperable Disease in 40 participants. Status unknown.

Timeline

1 January 2022

Primary endpoint
30 December 2022

30 December 2022

Quick facts

Lead sponsor	Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	40
Start date	1 January 2022
Primary completion	30 December 2022
Estimated completion	30 December 2022
Sites	1 location across Romania

Drugs / interventions tested

Endoscopic ultrasound with fine needle biopsy

Conditions studied

Inoperable Disease — all drugs for Inoperable Disease →
Bile Duct Cancer — all drugs for Bile Duct Cancer →

Sponsor

Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor

Who can join

Adults 18 to 99, any sex, with Inoperable Disease or Bile Duct Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

VALIDATION OF THE SUPERIORITY OF CONTRAST ENHANCED ENDOSCOPY TO STANDARD ENDOSCOPY IN THE DIAGNOSIS OF BILE DUCT TUMORS

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Inoperable Disease

Currently open trials in the same condition.

NCT06483347 — Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT · Phase 2 · recruiting
NCT05817604 — Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) · active not recruiting

Other Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor trials

Trials by the same sponsor.

NCT06216509 — Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements · NA · completed
NCT05474872 — Postoperative Delirium in the ICU Setting of an Eastern European Centre · unknown
NCT04449289 — Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery · Phase 2 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05418543 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor
Last refreshed: 15 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05418543.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing